Litcius/Paper detail

A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer

Zahra Rahimzadeh, Seyed Morteza Naghib, Esfandyar Askari, Fatemeh Molaabasi, Ali Sadr, Yasser Zare, Mandana Afsharpad, Kyong Yop Rhee

2021Nanotechnology Reviews39 citationsDOIOpen Access PDF

Abstract

Abstract In this paper, we use a simple and cheap approach for the synthesis of herceptin-conjugated graphene biosensor to detect the HER2-positive breast cancer cells. The bifunctional graphene-herceptin nanosheets are prepared from graphite by a simple ultrasonic-mediated technique. The prepared protein-mediated graphene is fully characterized. The results show the exfoliation of graphene layers in herceptin solution. Moreover, herceptin is effectively conjugated into the surface of graphene nanosheets. The synthesized herceptin-conjugated graphene is applied for breast cancer detection. The linear range of this biosensor is 1–80 cells, which is significant. The biosensor shows an excellent selectivity performance for detection of HER2-positive cancer cells. Likewise, the stability and functionality of the biosensor is about 40 days. Based on the results, this device is a promising candidate for rapid and selective detection of cancer cells.

Topics & Concepts

GrapheneBiosensorConjugated systemMaterials scienceNanotechnologyBreast cancerExfoliation jointCancerMedicinePolymerInternal medicineComposite materialGraphene and Nanomaterials ApplicationsAdvanced biosensing and bioanalysis techniquesGraphene research and applications
A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer | Litcius